M1-associated studies |
idopathic pulmonary fibrosis |
human |
- |
↑ expression of IL1β, collagen type I and III, fibronectin |
[99] |
cardiac fibrosis |
murine |
IL6 knockout |
↓ expression of αSMA, TGFβ1, collagen |
[112] |
bleomycin-induced fibrotic legions |
murine |
STAT3 knockout |
↓ expression of SOCS3, IL10, and decorin. ↑ expression of TGFβ1 |
[115] |
M2-associated studies |
scenescent muscle |
murine |
- |
↑ collagen, tissue stiffness, ↓ nNOS |
[118] |
scenescent muscle |
murine |
muscle-specific nNOS transgene |
↓ M2 macrophages and muscle fibrosis in older muscle tissue |
[87] |
endometriosis |
murine (Balb/C) |
- |
↓ M2 macrophages (CD163), ↑ collagen, αSMA, SMAD3, and CD41 |
[120] |
endometriosis |
murine (C57BL/6) |
macrophage ablation and adoptive transfer of M1, M2a, or M2c macrophages |
adoptive transfer of M2a macrophages (MRC1) ⟹ ↑ collagen I, TGFβ1, αSMA compared to M1 (iNOS) or M2c (VTCN1) |
[120] |
tissue fibrosis |
murine |
IL4Rα knockout |
↓ M2 markers (CD163, MRC1, PDGFB, IL10) and unchanged M1 markers (IL1β, TNFα, IL) vs. controls. M2a-derived RELMα ⟹ ↑ LH2 in fibroblasts |
[124] |
fibrotic chronic pancreatitis |
murine and human |
IL4Rα knockout, macrophage depletion, and IL4/IL13 blocking antibodies |
IL4/IL13 blocking ⟹ ↓ M2a macrophages and decrease in fibrosis |
[125] |
bleomycin-induced lung fibrosis |
murine |
IL13Rα2 blocking antibody |
↓ TGFβ1 and collagen deposition |
[126] |
heart-allograft fibrosis |
murine |
IL13Rα2 blocking via siRNA |
fibrosis was prevented |
[127] |
failing renal allograft |
human |
- |
CD68, aSMA, MRC1 |
[129] |
renal fibrosis |
murine |
SMAD3 knockout |
macrophage-myofibroblast transition |
[130] |